… a therapeutic gene expression cassette substitutes the viral E1 and/or E3 regions, have
advanced to clinical trials for applications in both therapeutic angiogenesis and heart failure. …

… Resveratrol has been widely studied for its therapeutic potential due to its antioxidant, anti-inflammatory
and anti-microbial properties. In particular, resveratrol has shown promising …

… This section is a review written with regard to the role of blood biomarkers and imaging in
heart failure for the Heart failure clinic journal. As conclusion, the multi-biomarkers strategy, in …

… Recent evidence has shed light on the therapeutic potential of the modulation of both GMB
and microbial metabolites in selected CVDs. The main therapeutic strategies designed to …

… survival have led to the increasing prevalence of heart failure in the US population 3 and in
… in aspects of heart failure and their potential as novel clinical and therapeutic biomarkers. We …

… of the energy metabolic changes that occur in heart failure. This includes distinguishing the
… , as well as heart failure associated with diabetes (ie, diabetic cardiomyopathy). Although we …

… with acute decompensated heart failure and is an important target for therapy. However, …
the outcomes of patients with acute decompensated heart failure. Although the majority of these …

… longa, is well known for its therapeutic potential in numerous disorders. However, there is
a lack of literature on the therapeutic potential of C. longa in contrast to curcumin. Hence, the …

… (AHF) is a syndrome defined as the new onset (de novo heart failure (HF)) or worsening (acutely
decompensated heart failure (ADHF)) of symptoms and signs of HF, mostly related to …

… -risk hypertension and heart failure with reduced ejection fraction, … in hypertension and heart
failure with reduced ejection … cardiovascular disease from hypertension to heart failure (HF). …